Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

Blog

  • Home
  •  
  • Blog



  • Most Read
  • Latest Comments
  • Blog
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Blog
    • Satire

    Australia to close borders to Omicron Persei 8
    Public
  • Blog
    • Opinion

    The New Criterion: will the listed sanitiser stocks clean up – or clean out – investors?
    Public
  • Blog
    • Opinion

    Is this the most hated company on the ASX?
    Public
  • Blog
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Is this the most hated company on the ASX?
    • Review
    • August 16, 2019

Latest Articles

  • AML3D announces stronger FY26, with positive EBITDA reported in the second half
    AML3D announces stronger FY26, with positive EBITDA reported in the second half
    • News

  • Refurbished tech gives Harris Technology a second life
    Refurbished tech gives Harris Technology a second life
    • News

  • Imagion Biosystems Advances MagSense® Phase 2 Trial
    Imagion Biosystems Advances MagSense® Phase 2 Trial
    • News

  • Acrux-developed Menopause Hormone Therapy to enter Australian market
    Acrux-developed Menopause Hormone Therapy to enter Australian market
    • News

  • Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    Evion Expands Critical Minerals Push with Nevada Fluorspar Option
    • News

  • Tech billionaire Richard White backs Kyckr, buying 19.6% stake in tech small cap
    • News

    Tech billionaire Richard White backs Kyckr, buying 19.6% stake in tech small cap

    Highlighting the importance of compliance and transparency for investors, a corporate governance breach by agriculture company CropLogic (ASX: CLI) has landed them on the ASX watch-list which will see their announcements and activity closely scrutinised by regulators for the foreseeable future.  The situation arose following a private query from the ASX to CropLogic as to

    Read More
    Public
  • Keytone Dairy adds complementary healthfoods range with Super Cubes acquisition
    • News

    Keytone Dairy adds complementary healthfoods range with Super Cubes acquisition

    As the Australian public continues trending towards health-conscious eating, dairy producer Keytone Dairy (ASX: KTD) is expanding into the segment via the acquisition of lifestyle health and wellness brand Super Cubes.  The purchase price of $263k cash, $463k debt settlement and issue of performance-based shares will provide Keytone with Super Cubes’ products as well as

    Read More
    Public
  • Savvy investor hoards petrol ahead of US-Saudi oil tensions
    • Satire

    Savvy investor hoards petrol ahead of US-Saudi oil tensions

    Hugh Honey is gearing up for a big payday after clearing out his local hardware store of plastic barrels and filling them with the commodity he expects to skyrocket in the coming days.  The commodity in question, petrol, is forecast to rise in price following drone attacks on a Saudi Arabian oil facility over the

    Read More
    Public
  • Looking for value in the Small Cap space
    • Opinion

    Looking for value in the Small Cap space

    There was a bit of a storm kicked up in the investment community recently when Michael Burry, an investor profiled in the Michael Lewis book (and subsequent film) The Big Short. Mr. Burry was famous for his bets on the American sub-prime mortgage market in anticipation of the Global Financial crisis. This time he made another

    Read More
    Public
  • Alcidion engaged by Healthscope to predict your healthcare needs
    • News

    Alcidion engaged by Healthscope to predict your healthcare needs

    If Doctor Google can diagnose your current ailments, medical informatics company Alcidion (ASX: ALC) may soon be predicting your future needs after being engaged by Healthscope to develop a data and analytics solution.  The agreement, valued at $895,000 over three-years, will see the two companies work together as Healthscope seeks to transform the way healthcare

    Read More
    Public
  • AdAlta partners with GE Healthcare to develop i-body diagnostic imaging
    • News

    AdAlta partners with GE Healthcare to develop i-body diagnostic imaging

    Melbourne-based drug development company AdAlta (ASX: 1AD) has been selected by GE Healthcare, one of the world’s largest healthcare companies, to develop ‘i-bodies’ which GE can use as imaging agents.  One-tenth of the size of regular antibodies, i-bodies are a new class of human protein therapeutic which can be applied as a therapeutic drug to

    Read More
    Public
  • «
  • ‹
  • 654
  • 655
  • 656
  • 657
  • 658
  • ›
  • »

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.